| Literature DB >> 35328621 |
Ana C Gonçalves1, José David Flores-Félix1, Paula Coutinho1,2, Gilberto Alves1, Luís R Silva1,2.
Abstract
Plant-derived products and their extracted compounds have been used in folk medicine since early times. Zimbro or common juniper (Juniperus communis) is traditionally used to treat renal suppression, acute and chronic cystitis, bladder catarrh, albuminuria, leucorrhea, and amenorrhea. These uses are mainly attributed to its bioactive composition, which is very rich in phenolics, terpenoids, organic acids, alkaloids, and volatile compounds. In the last few years, several studies have analyzed the huge potential of this evergreen shrub, describing a wide range of activities with relevance in different biomedical discipline areas, namely antimicrobial potential against human pathogens and foodborne microorganisms, notorious antioxidant and anti-inflammatory activities, antidiabetic, antihypercholesterolemic and antihyperlipidemic effects, and neuroprotective action, as well as antiproliferative ability against cancer cells and the ability to activate inductive hepato-, renal- and gastroprotective mechanisms. Owing to these promising activities, extracts and bioactive compounds of juniper could be useful for the development of new pharmacological applications in the treatment of several acute and chronic human diseases.Entities:
Keywords: Juniperus communis L.; bioactive compounds; biological potential; essential oils; in vitro studies; in vivo studies; phenolic compounds
Mesh:
Substances:
Year: 2022 PMID: 35328621 PMCID: PMC8952110 DOI: 10.3390/ijms23063197
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Juniperus communis (A) main view of the plant growing in Serra da Estrela, (B) detail of leaves, and (C) details of berries. Images under Creative Commons licence, authorship: João Domingues Almeida and Paulo Ventura Araújo from www.flora-on.pt, accessed on 10 March 2022.
Figure 2Main phytochemicals found in Juniperus communis L. (adapted from Fátima et al. [55]).
Total phenolic, flavonoid, anthocyanin, and tannin content of different Juniperus communis L. plant parts extracts.
| Gender | Origin | Extract | Total Phenolic Compounds a | Total Flavonoid | Total Anthocyanin Content c | Total Tannin Content b | References | |
|---|---|---|---|---|---|---|---|---|
| Leaves | ||||||||
| n.s. | Serra Da Estrela, Portugal | Methanolic | 155.60 | 60.40 | [ | |||
| n.s. | Yozgat, Turkey | Hydroethanolic (80% ethanol, | 4.36 | 7.05 | [ | |||
| n.s. | Yozgat, Turkey | Aqueous | 169.27 | 24.30 | ||||
| Female | Rhodopes, Bulgaria | Methanolic | 132.00 | [ | ||||
| Female | Mountain Ozren, near Sarajevo, Bosnia, and Herzegovina | Methanolic | 390.89 | 40.22 * | [ | |||
| Male | Mountain Ozren, near Sarajevo, Bosnia, and Herzegovina | Methanolic | 544.09 | 48.06 * | ||||
| n.s. | Nainital, India | Hydroethanolic (70% ethanol, | 238.78 | [ | ||||
| n.s. | Nainital, India | Hexane | 189.65 | |||||
| n.s. | Nainital, India | Ethyl acetate | 315.33 | |||||
| n.s. | Nainital, India | Aqueous | 205.33 | |||||
| Male | North Carolina, USA | Methanolic | 91.00 | [ | ||||
| n.s. | Turkey | Hydroethanolic | 212.10 | [ | ||||
|
| ||||||||
| n.s. | Yozgat, Turkey | Hydroethanolic | Ripe berry: 11.92 | Ripe berry: 2.56 | [ | |||
| n.s. | Yozgat, Turkey | Aqueous | Ripe berry: 4.36 | Ripe berry: 7.05 | ||||
| North-East Slovakia | Hydroethanolic | Ripe berry: 6.87–42.23 | [ | |||||
| n.s. | Melbourne, Australia | Hydroethanolic | Ripe berry: 9.08 | Ripe berry: 2.25 | [ | |||
| n.s. | Quebec, Canada | Hydroethanolic | Ripe berry: 99.20 b | Ripe berry: 0.47 | [ | |||
| n.s. | Serra Da Estrela, Portugal | Methanolic | Ripe berry: 44.70 | [ | ||||
| n.s. | Ağrı, Turkey | Methanolic | Ripe berry: 59.17 | [ | ||||
| n.s. | Pitesti hills, Romania | Hydroethanolic | Ripe berry: 0.19 | Ripe berry: 51.09 d | [ | |||
| n.s. | Yozgat, Turkey | Hydroethanolic | Ripe berry: 21.00 | [ | ||||
| n.s. | Ankara, Turkey | Methanolic | Ripe berry: 17.64 | [ | ||||
| n.s. | Šara mountain in south Serbia | Chloroformic | 189.82 | 27.11 d | [ | |||
| n.s. | Šara mountain in south Serbia | Ethanolic | 189.82 | 42.85 d | ||||
| n.s. | Šara mountain in south Serbia | Ethyl acetate | 144.21 | 38.40 d | ||||
|
| ||||||||
| n.s. | Serra Da Estrela, Portugal | Methanolic | 221.30 | 79.30 | [ | |||
n.s.: not specified; a mg equivalent of gallic acid (GAE) per g dry weight (dw); b mg quercetin equivalents per g dw; c mg cyanidin 3-glucoside equivalents per g dw; d mg quercetin 3-O-rutinoside equivalents per g dw; * mg of catechin equivalents per g dw.
Figure 3Main phenolic compounds found in Juniperus communis L. vegetal parts.
Figure 4The main volatile organic compound found in Juniperus communis L. parts.
Figure 5Main health-promoting properties attributed to Juniperus communis L. AST: aspartate aminotransferase; ALT: alanine aminotransferase; AChE: acetylcholinesterase; BChE): butyrylcholinesterase; Bax: Bcl-2-associated X protein; AIF: apoptosis-inducing factor; Fas: cell-surface death receptor; FasL: Fas ligand; Bcl-2: B-cell lymphoma 2; ↑: increase; ↓: reduction; T: inhibition.
Antimicrobial and antiparasitic activity of different Juniperus communis extracts.
| Part of the Plant | Origin | Subspecies/Variety | Method | Inhibited Species | References |
|---|---|---|---|---|---|
| Antimicrobial activity | |||||
| Essential oils | |||||
| Berries | Poland | n.s. | Disc diffusion | [ | |
| Needles | Portugal | var. | MIC and MLC | [ | |
| Needles and berries | Italy | var. | MIC | [ | |
| Plant material (leaves and stems) | Iran | n.s. | Disc diffusion | [ | |
| Berries | Slovenia | n.s. | Biofims assay |
| [ |
| Plant material (undifferentiated) | Slovenia | n.s. | Disc diffusion | [ | |
| Berries | Spain | n.s. | MIC | [ | |
| Berries | Portugal | n.s. | MIC and MLC | [ | |
| Leaves | Croatia | n.s. | Disc diffusion, MIC, and MLC | 16 species of bacteria and 14 species of fungus | [ |
| Berries | Serbia | n.s. | Disc diffusion, MIC, MLC, and in vivo adhesion assay | [ | |
| Plant material (leaves and branches) | Egypt | n.s. | MIC | [ | |
| Plant material | Croatia | n.s. | MIC and biofilm assay | [ | |
| Phenolic-rich extracts | |||||
| Berries | Slovenia | n.s. | Biofilms assay |
| [ |
| Plant material | Italy | n.s. | Disc diffusion and MIC | [ | |
| Berries | Turkey | n.s. | Disc diffusion and MIC | [ | |
| Leaves | Turkey | var. | MIC |
| [ |
| Leaves | Poland | n.s. | Disc diffusion | [ | |
| Stem (branches) | Italy | var. | Biofilm formation |
| [ |
| Berries | Turkey | var. | MIC and MLC | [ | |
| Leaves | India | n.s. | MIC | [ | |
| Antiparasitic activity | |||||
| Essential oils | |||||
| Stems and leaves | France | n.s. | Radioactive micromethod | Two different strains of | [ |
n.s.: not specified; MIC: Minimal inhibitory concentration; MLC: Minimal lethal concentration.
In vitro and in vivo antioxidant effects of Juniperus communis extracts.
| Part of the Plant | Origin | Extract | Subspecies/ | Experimental Model | Effect | References |
|---|---|---|---|---|---|---|
| In vitro assay | ||||||
| Berries | Romania | Ethanolic | n.s. | Capacity to scavenge DPPH● | IC50 value of 1.42 µg/mL | [ |
| Serbia | Ethanolic | IC50 value of 28.55 µg/mL | ||||
| Ethyl acetate | IC50 value of 106.44 µg/mL | |||||
| Chloroform | IC50 value of 257.66 µg/mL | |||||
| Poland | Methanolic | IC50 values from 6.86 to 13.66 µg/L | ||||
| Essential oils | IC50 varying from 1.27 to 4.25 µg/L | |||||
| Turkey | Methanolic | var. | IC50 value of 1.84 mg/mL | |||
| var. | IC50 value of 0.63 mg/mL | |||||
| Ethanolic | var. | Inhibitory percentages of 33.25, 34.27, and 36.26% at 0.5, 1, and 2 mg/mL, respectively | ||||
| Aqueous | Inhibitory percentages of 48.40, 63.29, and 82.03% at 0.5, 1, and 2 mg/mL, respectively | |||||
| Poland | Methanolic | n.s. | Reducing power potential | Values ranging 6.90 and 10.70 mM FeSO4 × 7H2O | [ | |
| Essential oils | Values ranging from 0.47 and 1.11 mM FeSO4 × 7H2O | |||||
| Turkey | Methanolic | var. | IC50 value of 12.82 mg/mL | |||
| 12.82 ascorbic acid equivalent/mL | ||||||
| var. | IC50 value of 64.14 mg/mL | |||||
| 64.14 ascorbic acid equivalent//mL | ||||||
| Ethanolic | var. | Inhibitory percentages of 0.083, 0.095, and 0.203% at 0.5, 1, and 2 mg/mL, respectively | ||||
| Aqueous | Inhibitory percentages of 0.424, 0.689, and 1.371% at 0.5, 1, and 2 mg/mL, respectively | |||||
| Poland | Methanolic | n.s. | [ | |||
| Essential oils | n.s. | |||||
| Turkey | Methanolic | var. | Protect liposomes from lipid peroxidation | IC50 value of 120.07 µg/mL | [ | |
| var. | IC50 value of 4.44 µg/mL | |||||
| Turkey | Methanolic | var. | Ferrous ion (Fe2+)-chelating activity | Chelating ability around 30% at 2 mg/mL | [ | |
| var. | Chelating ability around 15% at 2 mg/mL | |||||
| Ethanolic | var. | Inhibitory percentages of 4.88, 14.86, and 32.82% at 0.5, 1, and 2 mg/mL, respectively | ||||
| Aqueous | Inhibitory percentage of 0.83% at 2 mg/mL | |||||
| Canada | Ethanolic | var. | Capacity to scavenge peroxyl radicals | 3876 µM Trolox equivalents at 1 mg/mL | [ | |
| n.s. | Essential oil | n.s. | Capacity to scavenge ABTS•+ species | IC50 value of 10.96 µg/mL | ||
| Turkey | Ethanolic | var. | Capacity to scavenge ABTS•+ species | Inhibitory percentages of 42.5%, respectively at 3 mg/mL | ||
| n.s. | Essential oil | n.s. | Capacity to scavenge hydroxyl radicals | IC50 value of 0.0066 µg/mL | [ | |
| n.s. | Essential oil | n.s. | Capacity to scavenge superoxide anions | IC50 of 0.822 µg/mL | [ | |
| Turkey | Ethanolic | var. | Inhibitory percentages of 20.07, 21.97, and 17.80% at 0.5, 1, and 2 mg/mL, respectively | |||
| Aqueous | var. | Inhibitory percentages of 5.49, 10.61, and 11.17% at 0.5, 1 and 2 mg/mL, respectively | ||||
| Crushed berries | Slovakia | Ethanolic | n.s. | Capacity to scavenge hydroxyl radicals | Inhibitory values varying from 65.59 to 88.12% (recalculated by dry matter (DM), from 3.06 to 5.75%/g DM) | [ |
| Noncrushed berries | Slovakia | Ethanolic | n.s. | Inhibitory values varying from 15.52 and 32.85% (recalculated by dry matter (DM), from 1.20 to 20.05%/g DM) for | ||
| Unripe berries | Turkey | Ethanolic | var. | Capacity to scavenge superoxide anions | Inhibitory percentages of 14.58, 10.99, and 18.37% at 0.5, 1, and 2 mg/mL, respectively | [ |
| Capacity to scavenge DPPH● | Inhibitory percentages of 46.21, 57.32, and 73.75% at 0.5, 1, and 2 mg/mL, respectively | [ | ||||
| Capacity to chelate metals | Inhibitory percentages of 6.32, 5.04, and 16.59% at 0.5, 1, and 2 mg/mL, respectively | [ | ||||
| Ferric-reducing antioxidant power | Inhibitory percentages of 0.288, 0.504, and 0.855% at 0.5, 1, and 2 mg/mL, respectively | |||||
| Leaves | India | Ethanolic | n.s. | Capacity to scavenge DPPH● | IC50 value of 213 µg/mL | [ |
| Aqueous | var. | IC50 value of 347 µg/mL | ||||
| Ethyl acetate | IC50 value of 177 µg/mL | |||||
| Turkey | Ethanolic | var. | Inhibitory percentages of 66.62, 83.06, and 91.40% at 0.5, 1, and 2 mg/mL, respectively | |||
| Aqueous | Inhibitory percentages of 34.92, 35.56, and 37.29% at 0.5, 1, and 2 mg/mL, respectively | |||||
| Bulgaria | Methanolic | var. | IC50 value of 258 µg/mL | |||
| Serbia | Essential oil | var. | IC50 value of 660 µg/mL | |||
| Serbia | Essential oil | var. | Potential to chelate metals | IC50 value of 320 µg/mL | [ | |
| India | Ethyl acetate | var. | IC50 value of 261 µg/ | |||
| Turkey | Acetate | n.s. | Inhibitory effect of 6.05% at 1 mg/mL | |||
| Aqueous | var. | Inhibitory percentages of 9.06, 12.39, and 38.40% at 0.5, 1, and 2 mg/mL, respectively | ||||
| Turkey | Ethanolic | var. | Capacity to scavenge superoxide anions | Inhibitory percentages of 20.26, 25.00, and 25.38% at 0.5, 1, and 2 mg/mL, respectively | [ | |
| Turkey | Ethanolic | var. | Ferric-reducing antioxidant power | Inhibitory percentages of 0.681, 1.278, and 1.971% at 0.5, 1, and 2 mg/mL, respectively | ||
| Aqueous | Inhibitory percentages of 0.121, 0.120, and 0.154% at 0.5, 1, and 2 mg/mL, respectively | |||||
| Serbia | Distilled extracts | var. | Reduction capacity of 78.77 mg of ascorbic acid equivalents per g of dry matter | |||
| Serbia | Distilled extracts | var. | Lipid-peroxidation inhibitory potential | IC50 value of 540 µg/mL | [ | |
| Essential oils | IC50 value of 2440 µg/mL | |||||
| Turkey | Ethanolic | var. | Capacity to scavenge ABTS•+ species | Inhibitory percentage of 99.5 at 3 mg/mL | [ | |
| Shoots | Poland | Crude extract | n.s. | Antioxidant-enzyme activity and reactive oxygen species in vitro assays | ↑↑ the activity of intracellular antioxidant enzymes superoxide dismutase and catalase | [ |
| Turkey | Acetone | n.s. | Capacity to chelate metals | Inhibitory percentage of 6.05% at 1 mg/mL | [ | |
| Ethyl acetate | Inhibitory percentage of 22.59 at 1 mg/mL | |||||
| Ethanolic | Inhibitory percentage of 12.31% at 1 mg/mL | |||||
| Twigs | Spain | Essential oil | n.s. | Peroxy-radical-induced oxidation inhibition | 120 µmol Trolox/gram of essential oil | [ |
| Hops | Australia | Ethanolic | n.s. | Ferric ion-reducing antioxidant power | 4.17 mg of ascorbic acid equivalents per g | [ |
| Capacity to scavenge DPPH● | 9.26 mg of ascorbic acid equivalents per g | |||||
| Capacity to scavenge ABTS•+ species | 49.54 mg of ascorbic acid equivalents per g | |||||
| Plant material (twigs, leaves, and berries) | Spain | Essential oil | n.s. | Reducing power assay | IC50 values from 135 to 970 µg/mL | [ |
| Spain | Essential oil | n.s. | Inhibition of oxidation process | IC50 values from 324.76 to 1563.29 µg/mL | ||
| In vivo assay | ||||||
| Leaves | India | Methanolic | n.s. | Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg | ↑↑ in reduced glutathione | [ |
| Romania | Essential oil | n.s. | Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats | ↑↑ superoxide dismutase and catalase enzymes, and glutathione peroxidase activity | [ | |
n.s.: not specified; IC50: half-maximal inhibitory concentration; TBARS: thiobarbituric acid-reactive substances, DPPH●: 2,2-diphenyl-1-picrylhydrazyl radical; ABTS•+: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; ↑↑: increase; ↓↓: reduction.
In vitro and in vivo health benefits of Juniperus communis extracts.
| Part of the Plant | Origin | Extract | Subspecies/ | Experimental Model | Effect | References |
|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
| Plant parts | Sweden | Aqueous | n.s. | Prostaglandin biosynthesis assay | ↓↓ prostaglandins by 55% at 200 µg/mL | [ |
| Woods | Austria | Methylene chloride | n.s. | 12(S)-lipoxygenase assay | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 54.0% at 100 µg/mL, 66.2 and 76.2%, | [ |
| Berries | Austria | Methylene chloride | n.s. | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 66.2% at 100 µg/mL | ||
| Ethyl acetate | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 76.2% at 100 µg/mL | |||||
| Plant material (twigs, leaves, and fruits) | Spain | Essential oil | n.s. | Inhibition of nitric oxide production in lipopolysaccharide-activated murine macrophage RAW 264.7 cells | IC50 values from 23.98 to 84.80 µg/mL | [ |
|
| ||||||
| Berries | Italia | Hydroethanolic | var. | Effects on the inhibition of writhing carrageenin foot edema in male Wistar rats after 7 days of treatment at doses of 100 and 200 mg/kg | ↓↓ carrageenin-foot edema by 60% and 79% at 100 and 200 mg/kg, respectively | [ |
| Turkey | Aqueous | 12.8% inhibition (berries) | [ | |||
| Berries, leaves, and stems | Turkey | Methanolic | var. | 18.5% inhibition (stems) | ||
| Aqueous | var. | 9.1% inhibition (berries) | ||||
| Methanolic | 30.5% inhibition (berries) | |||||
| Aqueous | var. | Effects on stimulating response latency in male Swiss albino mice using a hot plate after administration of 100 mg/kg of extract | 4.27% inhibition (stems) | |||
| Methanolic | 4.40% inhibition (stems) | |||||
| Aqueous | var. | 3.26% inhibition (stems) | ||||
| Methanolic | 3.13% inhibition (stems) | |||||
| Aqueous | var. | Effects on carrageenin-induced hind-paw edema in male Swiss albino mice after 360 min of 100 mg/kg extract administration | 65.9% inhibition (stems) | |||
| Methanolic | 54.3% inhibition (stems) | |||||
| Aqueous | var. | 69.6% inhibition (stems) | ||||
| Methanolic | 65.7% inhibition (stems) | |||||
| Methanolic | var. | Effects on PGE2-induced hind-paw edema effects in male Swiss albino mice after 360 min of 100 mg/kg extract administration | 17.6% inhibition (stems) | |||
| Leaves | India | Methanolic | n.s. | In vivo study involving different nociceptive assays (acetic acid-induced writhing, formalin and tail-flick tests) in Swiss albino mice at 100 and 200 mg/kg | ↓↓ writhing response and the late phase related with the formalin test | [ |
| Berries | Romania | Hydroethanolic microemulsions | n.s. | Effects on paw edema in dextran-induced inflammation Wistar rats’ model | ↓↓ paw edema | [ |
| Berries | Romania | Hydroethanolic microemulsions | n.s. | Kaolin-induced inflammation in Wistar rats’ model | ↓↓ interleukins -1β and 6 expression | |
|
| ||||||
|
| ||||||
| Fruits | Turkey | Hydroethanolic | var. | Capacity to inhibit | Inhibitory value of 29.8% at 3 mg/mL | [ |
| Capacity to inhibit | IC50 value of 4.4 µg/mL | |||||
| Leaves | Turkey | Hydroethanolic | var. | Capacity to inhibit the | Inhibitory value of 84.3% at 3/mg/mL | |
| Capacity to inhibit the | IC50 value of 53.6 µg/mL | |||||
| Plant material | United Kingdom | Aqueous | n.s. | Effects on glucose movement | ↓↓ glucose diffusion by 6% at 50 g/L | [ |
|
| ||||||
| Berries | United Kingdom | n.s. | Streptozotocin-induced diabetic mice models for 40 days at doses of 1 g/400 mL | ↓↓ polydipsia | [ | |
| Spain | Aqueous | n.s. | Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at doses of 250 and 500 mg/kg | ↓↓ hypoglycemia in normoglycemic rats | [ | |
| Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at 125 mg/kg | ↓↓ blood glucose levels and mortality index | |||||
| Turkey | Oil dissolved in 0.5% of sodium carboxymethyl cellulose | n.s. | Effects on albino Wistar rats after 30 days of treatment at doses of 50, 100 and 200 mg/kg | ↓↓ total cholesterol, oxidized low-density lipoprotein, alanine aminotransferase, and aspartate transaminase levels | [ | |
| Plant | n.s. | Methanolic extracts | n.s. | Effects on streptozotocin-nicotinamide induced diabetic rats after 21 days of treatment at doses of 100 and 200 mg/kg | ↓↓ blood glucose levels, total cholesterol, triglycerides, low-density lipoprotein, and very-low-density lipoprotein cholesterols | [ |
| Herbal preparation also composed of | Croatia | Hydroethanolic | n.s. | Effects on alloxan-induced nonobese diabetic NOD mice after 7 days of treatment at 20 mg/kg | ↓↓ glucose and fructosamine levels | [ |
|
| ||||||
|
| ||||||
| Berries | Nepal | Aqueous | n.s. | Effects on OECM-1 human gingival squamous cancer cells after 24 h of exposure | Induce apoptosis, exhibiting an IC50 value of 46.20 µg/mL | [ |
| Plant material | n.s | Aqueous | n.s | Effects on CE81T/VGH human esophageal squamous cell carcinoma after 24, 48 and 72 h of exposure | Induce cell cycle arrest at the G0/G1 phase by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways | [ |
| Effects on CE48T/VGH human esophageal epidermoid carcinoma after 24, 48, and 72 h of exposure | Induce cell-cycle arrest at the G0/G1 phase, by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways | |||||
| USA | Distilled extracts | Effects on B16/F10 melanoma cells after 24 and 48 h of exposure | Induced apoptosis, decreased angiogenesis and metastasis, and diminished cancer stem-cell expression | [ | ||
| Leaves | Turkey | Methanolic | n.s. | Effects on C6 rat brain tumor and HeLa human cervix carcinoma cells after 24 h of exposure | IC50 value of 28.43 µg/mL (C6 rat brain tumor) | [ |
| Aerial parts | Egypt | Methanolic | n.s. | Effects on PC3 human prostate, HCT 116 human colon, and MCF7 breast cancer cells after 24 h of exposure | IC50 value of 23.8 µg/mL (PC3 cancer cells) | [ |
| Plant material | New Mexico, USA | Aqueous | n.s. | Effects on MCF-7/AZ breast cancer cells after 24 h of exposure | IC50 value of 50 µg/mL | [ |
| Spain | Essential oil | n.s. | Effects on NCI-H460 lung, MCF-7 breast, AGS gastric, and Caco-2 cancer cells after 24 h of exposure | IC50 values varying from 41.99 to 44.87 µg/mL (NCI-H460 cancer cells) | ||
| Berries | Australia | Methanolic | n.s. | Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure | IC50 value of 1383 µg/mL (Caco-2 cancer cells) | [ |
| Aqueous | n.s. | Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure | IC50 value of 1516 µg/mL (Caco-2 cancer cells) | |||
| Serbia | Essential oil and Distilled extracts | var. | Effects on A549 human lung adenocarcinoma epithelial cells after 24 h of treatment after 24 h of exposure | Induced apoptosis and arrested cell cycle in G2/M | [ | |
| USA | Distilled extracts | n.s. | Effects on HepG2 human hepatocellular cancer cells after 24, 48, and 72 h of exposure | IC50 values of 48.9, 42.3, and 43.9 µg/mL, after 24, 48, and 72 h of exposure, respectively | [ | |
| Effects on Mahlavu human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure | IC50 values of 64.9, 58.5, and 59.4 µg/mL, after 24, 48, and 72 h of exposure, respectively | |||||
| Effects on J5 human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure | IC50 values of 74.2, 67.2, and 53.2 µg/mL, after 24, 48, and 72 h of exposure, respectively | |||||
| Effects on HT-29 colon cancer cells after 24, 48, and 72 h of exposure | Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 | |||||
| Effects on CT-26 colon cancer cells after 24, 48, and 72 h of exposure | Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 | |||||
| Leaves and branches | Wyoming, USA | Essential oil | n.s. | Effects on SH-SY5Y human neuroblastoma cells after 24 h of exposure | IC50 value of 53.7 µg/mL | [ |
| Seed cones | Serbia | Essential oil | var. | Effects on HT-29 and HCT116 colon cancer cells after 24 h of exposure | IC50 value 125 µg/mL (HT-29) | [ |
| Distilled extracts | IC50 value 625 µg/mL (HT-29) | |||||
| Roots | China | Acetone | n.s. | Effects on N18 neuroblastoma cell lines after 24 and 48 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways | [ |
| Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 24 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways | |||||
| Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 48 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways | |||||
|
| ||||||
| Plant | USA | Distilled extracts | n.s. | Effects on melanoma tumor model in C57BL/6 mice after 23 days of treatment at a dose of 200 mg/kg | Cell-cycle arrest at the G0/G1 phase | [ |
| Berries | USA | Distilled extracts | n.s. | Effects in BALB/c nude mice injected with HepG2 liver cancer cells at a dose of 200 mg/kg | ↓↓ tumor size | [ |
| Effects in female BALB/c mice injected with CT-16 colon cancer cells at a dose of 200 mg/kg | Inhibited proliferation | [ | ||||
| Roots | China | Acetone | n.s. | Effects in male Foxn1 nu/nu mice injected with DBTRG-05MG human glioblastoma cells after 100 days of treatment at a dose of 200 mg/kg | Can penetrate the blood-brain barrier | [ |
|
| ||||||
|
| ||||||
| Leaves | Turkey | Hydroethanolic | var. | Capacity to inhibit acetylcholinesterase activity | 10.38% inhibition at 50 µg/mL | [ |
| Ripe Berries | Aqueous | 5.47% inhibition at 100 µg/mL | ||||
| Shoots | Ethyl acetate, ethanolic, and acetone extracts | n.s. | 21.34% inhibition at 100 µg/mL (ethyl acetate extract) | |||
| Inhibitory percentages varying from 32.34 to 41.97%% inhibition at 100 µg/mL (ethyl acetate extract) | ||||||
| Leaves | Ethyl acetate, ethanolic, and acetone extracts | n.s. | 20.02% inhibition at 100 µg/mL (ethyl acetate extract) | |||
| Ripe berries and leaves | Turkey | Aqueous | var. | Capacity to inhibit butyrylcholinesterase activity | 25.87 (berries) and 25.33% (leaves) inhibition at 50 µg/mL | [ |
| Hydroethanolic | 43.68 (berries) and 30.31% (leaves) inhibition at 50 µg/mL | |||||
| Unripe berries | Hydroethanolic | 44.17% inhibition at 50 µg/mL | ||||
|
| ||||||
| Leaves | n.s. | Methanolic | n.s. | Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg | ↑↑ locomotor activity | [ |
| Plant material | India | Methanolic | Effects on Wistar rats with induced catalepsy by reserpine 4 h after juniper treatment at a dose of 200 mg/kg | ↓↓ catalepsy activity | [ | |
| Romania | Essential oil | Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42) male Wistar rat model of Alzheimer’s disease after 21 days of treatment | ↑↑ working memory and reference memory errors within radial arm maze task | [ | ||
| Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats | ↑↑ acetylcholinesterase, superoxide dismutase and catalase activities, and malondialdehyde and protein carbonyl levels | [ | ||||
|
| ||||||
|
| ||||||
| Leaves | India | Ethyl acetate | n.s. | Effects on Wistar albino rats with hepatic damage caused by paracetamol for 14 days at a dose of 200 mg/kg | ↓↓ alkaline phosphatase (−57.41%), direct bilirubin (−30.33%) and total bilirubin (−38.41%), serum alanine aminotransferase (−34.17%), and serum aspartate aminotransferase (−27.58%) when compared to the untreated group | [ |
| Stems | n.s. | Petroleum ether, chloroform, and ethanol extracts | n.s. | Effects on rats with hepatic damage caused by carbon tetrachloride | Hepatoprotective activity | [ |
| Co-combination of berries from juniper and | India | Ethanolic | n.s. | Effects on Wistar albino rats with liver toxicity induced by paracetamol and azithromycin for 14 days at a dose of 200 mg/kg | ↓↓ serum glutamate oxaloacetate transaminase (−65.4%), serum glutamate pyruvate transaminase (−59.3%), alkaline phosphatase (66.8%), total bilirubin (62.1%), and liver inflammation | [ |
|
| ||||||
|
| ||||||
| Berries | Republic of Korea | Methanolic | n.s. | Capacity to inhibit tyrosinase activity | about 50% inhibition at 100 µg/mL | [ |
|
| ||||||
|
| ||||||
| Berries | Croatia | Aqueous | n.s. | Daily intake of 10% aqueous infusion, 0.1% of oil (with 0.2% Tween 20 solubilizer) by healthy female Wistar rats | ↑↑ diuresis and urine excretion without loss of electrolytes | [ |
|
| ||||||
|
| ||||||
| Berries | Iran | Hydroethanolic | n.s. | Capacity to dissolve urinary stone brought out from human kidney at concentrations of 500, 1000, and 2000 µg/mL | Dissolve urinary stones | [ |
|
| ||||||
|
| ||||||
| Leaves | India | Methanolic | n.s. | Effects on adult male Wistar albino rats with ulcers induced by aspirin, serotonin, indomethacin, alcohol, and stress at doses of 50 and 100 mg/kg | ↓↓ aspirin, serotonin, indomethacin, alcohol, and stress-induced gastric ulcerations in rats | [ |
| n.s. | Effects on pigs with histamine-induced duodenal lesions at doses of 50 and 100 mg/kg | ↓↓ histamine-induced duodenal lesions in pigs | ||||
|
| ||||||
|
| ||||||
| Berries | Romania | Aerosols | n.s. | Effects of 3-week juniper aerosols (40 min/day) on female Sprague-Dawley rats firstly exposed to daily passive smoking for 6 weeks | ↓↓ acetylcholine endothelial-dependent relaxation | [ |
| Oil | n.s. | Effects of 3-week juniper nebulization (20 min/day) on the respiratory tract of rats which firstly exposed to 2 cigarettes per day, 5 days a week for 6 weeks | Bronchodilator effects mediated by nitric oxide | [ | ||
|
| ||||||
|
| ||||||
| Berries | Romania | Hydroethanolic | n.s. | Capacity to exhibit genoprotective effects against aberrations and abnormalities induced by ethanol on root-tip cells of | Can effectively protect chromosomes aberrations | [ |
n.s.: not specified; IC50: half-maximal inhibitory concentration ↑↑: increase; ↓↓: reduction.